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ABSTRACT: Kuwotypes of ditllerent cellulur populati(ms made ufter sepura / ion  of bone mt l r roa  cells 
on a grad ient  of Percol l  were evuluutod in seven pat ients  a)fe(:ted by chron ic  myelomanocytie 
leukemia diagnosed occarding to FAB crilerio. Mcgakar3 ocy/cs,  mnnocytic ells, und gr(nm- 
lacytic and erythroid precursors were prefere, utiully collected after  cctllrifugalion betweee 
density layers  of 1045 1050 mo/ml. 1050 I060 mg/ml, ul~d 1065 1070 mg/ml, respectively. 
The enriched cell fl'uctiuns were cultured separutely ulld submitted lo crtogenelic im~estigu- 
l ion after sbart-term culture. Some chramosomc uben'al io l~s (5(I ,+8) were observed h~ idl 
cclluh," f rac t ions  in three pat ients ,  thus providing cytogenctic e~ idence af the invnh,cmenl ot 
u common progenitor stem cell in this myelodysplustic disorder. On the other hun& chro- 
mosome abnormalities uch as del(3)lq21j uml del(ll)(q23) ( ippeared to be clm(illcd to the 
megakuryacytic and tim monocytic fractions, rCsl)ectix'ely, in two putients. It is coneeir(ll~lc 
thut lineugc-restricled uberr(ltions may develop us u c(mscqtw, ucc, o1" u multistep el(real mo-  
luIion and nlav show e cl(ise relatilmship with the hemapaietic di.lll'e, res~tiutive f)rl lcesses. 
INTRODUCTION 
Chronic myelomonocyt ic  leukemia (CMMol) is a myeloproliferative disorder re- 
cently included by the FAB Cooperative Group among the myelodysplastic syn- 
dromes [1]. This classification, while introducing a sharper definition of the disease, 
has provided the basis for studies leading to a better delineation of its clinical and 
biologic aspects [2, 3]. The cytogenetic features of CMMoL have recently been eval- 
uated in studies carried out on a large series of patients, confirming the observation 
of previous reports [3, 4] of the occurrence of nonrandom chromosome abnormali- 
ties in about 30% of the cases. Most of these aberrations are not specific for this 
disease and appear to be shared by other myeloid malignancies [5, 6]. 
Since CMMoL is considered a disorder of a pluripotent progenitor stem cell [71, 
the involvement of multiple hemopoietic lineages is a common feature in most of 
the patients. Thus the cytogenetic analysis of bone marrow cells separated on a 
density gradient [8] in order to obtain relatively pure cell populations may repre- 
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Cytogenetics of Enriched Cell Fractions in CMMoL 31 
sent an interesting tool for the assessment of the distribution of the chromosome 
abnormalities and the detection of lineage-restricted aberrations. The results of a 
cytogenetic study performed on bone marrow cells after separation on a Percoll 
density gradient are presented and discussed in this report. 
PATIENTS AND METHODS 
The patients were admitted to our institution between January 1984 and December 
1986, and diagnosis was made in accordance with the FAB criteria [1]. Bone mar- 
row aspiration smears were stained both with the May Grunwald-Giemsa method 
and with cytochemical reactions [Prussian Blue, Sudan Black B (SBB), naphthol 
AS-D chloroacetate sterase (NASDCAE), and alpha-naphthyl acetate esterase 
(ANAE) with and without fluoride inhibition]. 
Separation of Bone Marrow Cells 
Mononuclear cells (30 x 106) were layered on top of a Percoll gradient in sterile 
polypropylene tubes and centrifuged at 600 g for 30 minutes. The densities used 
were 1070 mg/ml, 1065 mg/ml, 1060 mg/ml, 1055 mg/ml, 1050 mg/ml, and 1045 rag/ 
Figure 1 Cellular populations atdifferent Percoll densities are shown, a. 106(}-1f]50 mg/ml 
fraction. The cytospin preparation was stained with combined reactions for ANAE and 
NASDCAE. A scattered graimlar posilivity for the nonspecific esterase is present in most ol 
the elements. A granulocytic precursor positively stained for NASDCAE is arrowed, b. Cells 
collected at 1050 1[]45 mg/ml density stained with anti-factor Vlll-related antigen monoclonal 
antibody coupled with the immunoalkaline phosphatase t chnique are shown. 
~r 
J 
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ml from the bottom to the top, and the volume of each layer was 1.2 ml. Fraction- 
ated cellular populations were collected at the interfaces of the different densities, 
washed twice in TC Medium 199 (GIBCO), and cultured in RPMI-1640 medium 
(GIBCO) supplemented with 15% fetal calf serum and antibiotics at 37°C in 5% CO2 
humidified atmosphere. Cytospin preparations obtained from each culture were 
stained by means of cytochemical nd cytoimmunologic procedures [periodic acid- 
Schiff, NASDCAE, ANAE (+ NaF), anti-factor VIII related antigen monoclonal anti- 
body coupled with immunoalkal ine phosphatase t chnique] for a cytologic charac- 
terization. 
Cytogenetic Investigation 
Each cell fraction was processed for chromosome analysis according to conven- 
tional procedures after 6-72 hours' culture incubation. Air-dried slides were sub- 
mitted to ASG and trypsin banding methods [9, 10]. As many metaphases as pos- 
sible of each preparation were analyzed and karyotyped according to the ISCN 
nomenclature [11]. 
RESULTS 
The data concerning the clinical and hematologic appearance at presentation con- 
firmed the existence of distinct characteristics in this myelodysplastic syndrome 
[2]. Bone marrow was hypercellular in all the patients, with a marked increase of 
granulomonocytic precursors. Five patients presented important dyserythropoietic 
features; dysgranulopoiesis (three cases) and marked dysmegakaryocytopoiesis (one 
case) were also observed. Detailed hematologic data and unfractionated bone mar- 
row karyotypes are given in Table 1. 
The separation of bone marrow cells was successful in all patients, and the en- 
Table 2 Distribution patterns of various ceil populations in seven 
patients with CMMoL assessed by cytochemical nd 
cytoimmunologic techniques 
Prevailing cytologic type at Perco[l densities 
Patient 1070 1065 mg/ml "1060 1050 rag/m[ -"1050 mg/ml 
1. Ebls: 21% Mono-l: 48% 
PM-M: 72% Mybls: 33% 
2. Ebls: 27% Mono-l: 43% 
PM-M: 68% Mybls: 41% 
3. gbls: 48% Mono-l: 18% 
PM-M: 45% Mybls: 71% 
4. Ebls: 44% Mono-l: 56% 
PM-M: 50% Mybls: 40% 
5. Ebls: 28% Mono-l: 71% 
PM-M: 61% Mybls: 26% 
6. Ebls: 44% Mono-l: 22% 
PM-M: 54% Mybls: 76% 
7. gbls: 31% Mono-l: 40% 
PM-M: 63% Mybls: 47% 
Mono-[ + Mvbls: 70'14 
Mk-l: 22% 
Mono-I + Mvbls: 54% 
Mk-I: 38% 
Mono-l+Mvbls: 81% 
Mk-I: 11% 
Mono-I + Mvbls: 86% 
Mk-l: 8% 
Mono-I + Mvbls: 80% 
Mono-I + Mvbls: 78% 
Mk-l: 10% 
Mono-I + Mvbls: 73% 
Mk-l: "l.q% 
Difteronlial on cytospin preparation slides (200 cells observed). 
Abbreviations: Ebls. Erylhroblasts: PM-M. pronlvelocvtes and myelocytes: Morn>l, ~x;lls ol 
the monocytic lineage: Mybls. myeloblasts: Mk-l. <ells ot tim megakarvocylic lineage. 
Cytogenetics of Enriched Celt Fractious in CMMoL 33 
riched cellular fractions collected between the 1970-1065, 1060-1055-1050, and 
1050-1045 mg/ml densities were suitable for cytogenetic investigation. As revealed 
by the staining procedures, these fractions were constituted by erythroblasts and 
granulocytic precursors, by myeloblasts and monocytic cells, by megakaryocytes, 
and by both myeloid and monocytic immature cells, respectively, (Fig. 1). The dis- 
tribution pattern of various cell populations is given in Table 2. 
The cytogenetic nvestigations were performed after a 6-hour incubation from the 
erythroblast enriched fraction, after 24-48 hours from the monocytic fraction, and 
after 24-72 hours from the megakaryocyte-enriched c llular population. Results 
were reported in Table 3. All the cultured cellular fractions exhibited a trisomy of 
chromosome 8 in two patients (cases 4 and 6) and a terminal deletion of chromo- 
some 5 with breakpoint at band q31 in one patient (case 3). On the other hand, 
some chromosome aberrations, such as del(3)(q21) (patient 2, Fig. 2) and 
del(11)(q23) (patient 1, Fig. 3) presented a more selective distribution involving the 
megakaryocyte- and monocyte-enriched cell fractions, respectively. 
DISCUSSION 
Standard cytogenetic techniques do not permit recognition of the cytologic type of 
the dividing cells, thus causing a major problem in the analysis of myeloprolifera- 
rive disorders where the involvement of a common progenitor stem cell gives rise 
to a multi l inear hempoietic impairment. Recently, the introduction of a method for 
the simultaneous tudy of cell morphology and karyotype offered the chance to 
assign numerical chromosome aberrations to immunological ly identified cell lines 
[12]. Alternatively, a chromosome analysis of enriched cellular fractions after sep- 
aration on a density gradient might represent an effective contribution to a better 
Table 3 Karyotypic patterns of enriched cell fractions in seven patients with CMMoL 
Percoll densities (rag/hill--culture times (hr) 
No. No. No. 
of of of 
Patient cells 1070 1065 (6 hr) cells 1060-1050 (24 48 hr) (:ells 1050 -1045 (24 72 hr) 
1. 9 NN NN 
1 46.XX,del(5)(q311 46,XX. 10,+21.deI{5}(q31) 
45,XX. 16 
2, 10 NN NN 
46,XY,del(3){q21 
47,XY, + 21 
3. NN 
46,XY.del(5){q31 
44,XY, 19, 22,del(5}(q31) 
47,XY, - 14 
4. 47,XY.+8 
50,XY,+8,+ 12, + 13,+ 2O 
NN 
5. 
6. 
4 NN 
3 46,XY,del(5)(q31) 
2 47,XY. + 20,del(5)(q31) 
2 45,XY. 15 
1 47,XY, + 8 
5 46,XY,+ 8,-  22 
2 46,X, Y,+8,del(20)(p121 
3 45.XY,- 13 
10 NN 
4 46,XX, + 8.- 18 
2 47,XX,+ 21 
3 NN 
9 NN 
6 NN 6 
4 46.XX.del(11](q23) 2 
2 46,XX,- 6. + 20 3 
9 NN 11 
2 47,XY,+ 21 4 
1 
8 NN 7 
5 46.XY,del(5)(q31) 1 
1 46.XY,+20, 22,del(5)(q31) 2 
2 46,XY,t(l:2)(q32:q36) 2 
2 47,XY, + 8 5 
5 45,X, Y,+8,-22 2 
3 NN 3 
8 NN - -  Inadequate sample 
4 45,XX,+8, 18, 20 2 47,XX,+8 
2 46,XX,+8, 18 1 NN 
3 NN 
lO NN 7 NN 
Abbreviution: NN, normal karyotype, 
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I .  t 
1 2 3 4 5 
6 7 8 9 10 11 12 
13 14 15 16 17 18 
19 20 21 22 X Y 
Figure 2 The karyotype obtained from 1050-1045 mg/ml megakaryocyte-enriched ell frac- 
tion (patient 2) is shown. The terminal deletion of chromosome 3 is arrowed. 
definition of the cytogenetic aspects of the different hemopoietic lineages in this 
group of hematologic malignancies. As far as the cytogenetic results are concerned, 
our data parallel those given in previous reports [5, 13, 14]: nevertheless, ome 
comments hould be made regarding the methodologic approach. One patient (case 
2) presented relevant dysmegakaryocytopoiesis with high platelet counts associated 
with a 3q21 aberration detected in metaphases preferentially arising in the 1050 
1045 mg/ml fraction. Since normal karyotypes were exhibited by erythroid and im- 
mature myeloid cells, this abnormality seems to be confined to the megakaryocyte- 
enriched cell fraction. This cl inical-cytogenetic association has been described in 
different myeloproliferative disorders [13, 15-18], suggesting the existence in this 
region of a regulatory locus for thrombopoiesis. 
Abnormalit ies of chronmsome 11 have been reported only occasionally in 
CMMoL and myelodysplasia [19,201, whereas 11q23 rearrangements are considered 
typical of leukemic proliferations with monoblastic differentiation [21-231. One pa- 
tient (case 1) with hyperplastic features of the monocytic lineage and an increase 
of immature monocytes exhibited a clone carrying an 11q-  abnormality among the 
metaphases arising in the monocytic cellular fraction. This cytogenetic finding is 
not surprising for a patient with a dysplastic monocytic lineage since its relation- 
ship with the differentiation of monocytes has already been pointed out [24, 251. 
Interestingly, this abnormality was only present in the preparation harvested after 
48 hours' incubation and was not detected after 72 hours' culture in the 1045-1050 
Cytogenetics of Enriched Cell Fractions in CMMoL 35 
-,11 t 11 i tF 
1 2 3 4 5 
6 7 8 9 10 11 12 
13 14 15 16 17 18 
D '~ ~'~ ~"  ~ ' i ' ~  
20 21 22 X Y 
The karyotype obtained from 1060-1050 mg/ml monocyte-enriched cell fraction 
(patient 1) showing a terminal deletion of chromosome 11 is presented. 
19 
Figure 3 
mg/ml fraction where 20% monocytic ells were present. This finding seems to em- 
phasize the role played by culture time in cytogenetic analysis and gives evidence 
of the different mitotic activity of bone marrow cells during short-term culture [26]. 
It is thus likely that the kinetic features and low proliferative capacity that seem to 
characterize this clone [24] impede its detection in cytogenetic preparations ob- 
tained from whole bone marrow samples, possibly accounting for its absence in 
previous cytogenetic reports. 
Some of the chromosome aberrations detected in our patients ( + 8,5q- ) are typ- 
ical of leukemic myeloid proliferations and have alrady been described in this my- 
eloproliferative disorder. Their distribution appeared not to be correlated with the 
cytologic omposition of the cellular fractions, thus providing cytogenetic evidence 
for the involvement of a common progenitor stem cell in this myelodysplastic syn- 
drome [27]. It is conceivable that some steps in the progression of the disease might 
be represented by the occurrence, in either a multipotent or a committed hemo- 
poietic progenitor, of genetic aberrations causing growth advantage or maturation 
impairment of single marrow cell lineages. 
This work was supported by CNR-Rome grant 87.01221.44. 
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